Amgen Inc (AMGN) Receives a Buy from Mizuho Securities

By Carrie Williams

Mizuho Securities analyst Salim Syed maintained a Buy rating on Amgen Inc (AMGNResearch Report) on February 22 and set a price target of $211. The company’s shares closed yesterday at $190.08.

According to TipRanks.com, Syed is a 3-star analyst with an average return of 4.6% and a 55.2% success rate. Syed covers the Healthcare sector, focusing on stocks such as Atara Biotherapeutics, Wave Life Sciences, and Gilead Sciences.

Currently, the analyst consensus on Amgen Inc is a Moderate Buy with an average price target of $212.83, implying an 12.0% upside from current levels. In a report issued on February 20, Morgan Stanley also maintained a Buy rating on the stock.

See today’s analyst top recommended stocks >>

Amgen Inc’s market cap is currently $119.5B and has a P/E ratio of 15.08. The company has a Price to Book ratio of 9.57.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.